SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-19-039565
Filing Date
2019-07-08
Accepted
2019-07-08 16:01:34
Documents
2
Period of Report
2019-07-08

Document Format Files

Seq Description Document Type Size
1 3 a3.html 3  
1 3 a3.xml 3 1546
2 EX-24.1 ex-24d1.htm EX-24.1 7298
  Complete submission text file 0001104659-19-039565.txt   10387
Mailing Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827
Business Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827 908-200-7500
Celldex Therapeutics, Inc. (Issuer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 175 TOYOTA PLAZA, 7TH FLOOR MEMPHIS TN 38103
Business Address
Young Diane C. (Reporting) CIK: 0001648010 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-15006 | Film No.: 19945376